Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis
NCT ID: NCT00894231
Last Updated: 2009-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
30 participants
INTERVENTIONAL
2009-01-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis
NCT00439712
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
NCT00653224
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
NCT00524836
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
NCT00621959
The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism
NCT01008592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
Sugar tablet
placebo
sugar tablet
Xyzal
levocetirizine (Xyzal)
5mg po QD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
levocetirizine (Xyzal)
5mg po QD
placebo
sugar tablet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of PAR for 6-12 months greater
* 12 years and older
* Decreased nasal NO values at baseline
* Compliance and ability to perform maneuvers and responsibilities
Exclusion Criteria
* Inhaled, nasal, nebulized steroids w/i 4 weeks
* Hospitalization or life threatening asthma
* Use of nasal or oral antihistamines w/i 4 weeks
* Upper or lower airways infection
* Direct cigarette smoke exposure
12 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UCB Pharma
INDUSTRY
AAADRS Clinical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AAADRS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miguel J Lanz, MD
Role: PRINCIPAL_INVESTIGATOR
AAADRS Clinical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AAADRS
Coral Gables, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIS071108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.